Alajenio, Lucila L.

HRN: 29-11-83  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/09/2026
CEFTRIAXONE 1G (VIAL)
06/09/2026
06/16/2026
IV
2g
OD
CAP-MR
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: